Traxion Therapeutics traxiontx.com


Public lists: Pharma Startups (6570)

Traxion Therapeutics Inc. is a biotech company focused on the development of drugs for the treatment of intractable pain, specifically neuropathic pain. Traxion has assembled a portfolio of small molecule products to address this market opportunity. These products use more selective, mechanism-based approaches which exploit recent scientific discoveries in order to develop what Traxion believes are more effective, better tolerated treatments for neuropathic pain.

Traxion Therapeutics Inc. is a biotech company focused on the development of drugs for the treatment of intractable pain, specifically neuropathic pain. Traxion has assembled a portfolio of small molecule products to address this market opportunity. ...Show all

Company (Alive / Active)

Phone:

Fax:

1450 South Rolling Road
Baltimore, 21227
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Traxion Therapeutics $0M Oct 10, 2019
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Traxion Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Arcion Therapeutics

Baltimore, Maryland, United States
Alive / ActiveArcion Therapeutics applies breakthroughs in neuroscience to advance the treatment of chronic pain. The company focuses on topical treatments to provide pain relief with convenient application and reduced systemic side effects. Arcion's core technology is based on research which showed that in many neuropathic pain conditions, the signal that triggers pain actually arises at the level of the skin. This finding provides a strong biological rationale for developing topically delivered drugs to tar...Show allLogin to see details

Neuromed Pharmaceuticals

Vancouver, British Columbia, Canada
MergedLaunched in 1998, Neuromed is a biopharmaceutical company focused on the development of small molecule drugs targeting neuronal calcium channels to treat neurological disorders with the initial emphasis on chronic pain anxiety and strokeLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)